Julie Hambleton, a director at SpringWorks Therapeutics Inc . (NASDAQ:SWTX), recently sold shares valued at approximately $730,206, according to a recent SEC filing. The transaction involved the sale ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback